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Available online 1 December 2010Purinergic receptors are present in the lateral parabrachial nucleus (LPBN), a pontine
structure involved in the control of sodium intake. In the present study, we investigated the
effects of α,β-methyleneadenosine 5′-triphosphate (α,β-methylene ATP, selective P2X
purinergic agonist) alone or combined with pyridoxalphosphate-6-azophenyl-2′,4′-
disulfonic acid (PPADS, P2X purinergic antagonist) or suramin (non-selective P2 purinergic
antagonist) injected into the LPBN on sodium depletion-induced 1.8% NaCl intake. Male
Holtzman rats with stainless steel cannulas implanted into the LPBN were used. Sodium
depletion was induced by treating rats with the diuretic furosemide (20 mg/kg of body
weight) followed by 24 h of sodium-deficient diet. Bilateral injections of α,β-methylene ATP
(2.0 and 4.0 nmol/0.2 μl) into the LPBN increased sodiumdepletion-induced 1.8% NaCl intake
(25.3±0.8 and 26.5±0.9 ml/120 min, respectively, vs. saline: 15.2±1.3 ml/120 min). PPADS
(4 nmol/0.2 μl) alone into the LPBN did not change 1.8% NaCl intake, however, pretreatment
with PPADS into the LPBN abolished the effects of α,β-methylene ATP on 1.8% NaCl intake
(16.9±0.9 ml/120 min). Suramin (2.0 nmol/0.2 μl) alone into the LPBN reduced sodium
depletion-induced 1.8% NaCl intake (5.7±1.9 ml/120 min, vs. saline: 15.5±1.1 ml/120 min),
without changing 2% sucrose intake or 24 h water deprivation-induced water intake. The
combination of suramin and α,β-methylene ATP into the LPBN produced no change of 1.8%
NaCl intake (15.2±1.2 ml/120 min). The results suggest that purinergic P2 receptor activation
in the LPBN facilitates NaCl intake, probably by restraining LPBN mechanisms that inhibit
sodium intake.
© 2010 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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Important inhibitory mechanisms in the control of water, and
particularly NaCl, intake are located in the lateral parabrachial.
.M. De Paula).
giotensin II; ATP, Adeno
oventricular; LPBN, latera
the Elsevier OA license.nucleus (LPBN), a pontine structure that lies dorsolateral to the
superior cerebellar peduncle (Edwards and Johnson, 1991;
Menani and Johnson, 1995; Colombari et al., 1996; Menani et
al., 1996, 1998a,b, 2000).sine 5′-triphosphate; CCK, cholecystokinin; CNS, central nervous
l parabrachial nucleus; PPADS, pyridoxalphosphate-6-azophenyl-
Fig. 1 – Photomicrograph showing the sites of injections into
the LPBN (arrows). scp, superior cerebellar peduncle
(outlined).
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ysergide, a serotonergic receptor antagonist, into the LPBN
increased water and 1.8% NaCl intake induced by angio-
tensin II (ANG II) administered either intracerebroventri-
cularly (i.c.v) or into the subfornical organ (SFO) (Colombari
et al., 1996; Menani et al., 1996). Methysergide injected
bilaterally into the LPBN also increased NaCl intake
induced by subcutaneous (s.c.) injection of the diuretic,
furosemide (FURO), in combination with a low dose of the
angiotensin converting enzyme inhibitor, captopril, where-
as 2,5-dimetoxy-4-iodoamphetamine hydrobromide (DOI)
(a serotonergic 5-HT2A/2C receptor agonist) into the LPBN
reduced NaCl intake induced by FURO+captopril (Menani
et al., 1996). In addition to serotonin, cholecystokinin (CCK)
injected into LPBN inhibited NaCl and water intake
(Menani and Johnson, 1998). These studies suggested that
signals that inhibit sodium intake are integrated in the
LPBN, and involve the release of serotonin and CCK in this
area.
In addition to serotonin and CCK, glutamate, corticotro-
phin releasing factor (CRF), noradrenaline, GABAergic and
opioid receptors in the LPBN are involved in the control of
sodium intake (Menani et al., 1996, 1998a,b, 2000; De Gobbi et
al., 2000, 2009; Fratucci De Gobbi et al., 2001, Andrade et al.,
2004, 2006; Callera et al., 2005; De Castro e Silva et al., 2006; De
Oliveira et al., 2008; Andrade-Franzé et al., 2010; Gasparini et
al., 2009). Some of these neurotransmitters, like serotonin,
CCK, glutamate and CRF, act in the LPBN to inhibit sodium and
water intake, whereas noradrenaline, GABAergic and opioid
agonists act in the LPBN to facilitate sodium intake. All these
studies suggest that facilitation or inhibition of sodium intake
is probably related to activation or suppression of inhibitory
LPBN mechanisms.
Adenosine-5'-triphosphate (ATP) was first recognized as
extracellular signaling molecule and neurotransmitter/neu-
romodulator by Burnstock (1972). ATP binds to two classes of
purinergic receptors: the ionotropic P2X and the metabo-
tropic P2Y receptors (Ralevic and Burnstock, 1998). Several
functional studies have suggested that ATP and purinergic
receptors participate in central pathways involved in cardio-
respiratory and thermal regulation (Ergene et al., 1994;
Barraco et al., 1996; Phillis et al., 1997; Scislo et al., 1997,
1998; Gourine et al., 2002, 2003, 2004, 2005; de Paula et al.,
2004; Antunes et al., 2005a,b). Purinergic receptors are
present in central areas involved in the control of fluid–
electrolyte balance, particularly in the LPBN (Yao et al., 2000);
however, to our knowledge, the involvement of ATP or
purinergic receptors in the control of thirst or sodium
appetite has not been investigated.
Considering the importance of LPBN inhibitory mecha-
nisms for the control of water and NaCl intake and the
existence of purinergic receptors in the LPBN, in the present
study we investigated the effects of bilateral injections of a
non-selective P2 purinergic receptor antagonist suramin or a
selective P2X purinergic receptor antagonist pyridoxalpho-
sphate-6-azophenyl-2',4'-disulfonic acid (PPADS) and the
P2X purinergic receptor agonist α,β-methyleneadenosine
5′-triphosphate (α,β-methylene ATP) alone or combined
into the LPBN on sodium depletion-induced 1.8% NaCl
intake.2. Results
2.1. Histological analysis
Fig. 1 is a photomicrograph of a transverse section of the
brainstem of one rat, representative of the groups tested,
showing the typical bilateral injections into the LPBN. The
LPBN injection sites were centered in the central lateral and
dorsal lateral portions of the LPBN (see Fulwiler and Saper,
1984, for definitions of LPBN subnuclei). The LPBN injection
sites in the present study were similar to those from previous
studies showing the effects of serotonergic or cholecystoki-
nergic antagonists and gabaergic or opioid agonists on sodium
intake (Menani et al., 1996; Menani and Johnson, 1998; De
Gobbi et al., 2000; Fratucci De Gobbi et al., 2001; Callera et al.,
2005; De Oliveira et al., 2008).
From the total of 85 animals tested, 49 rats had bilateral
injections correctly placed into LPBN. Misplaced injections
that reached tissue surrounding the LPBNwere locatedmainly
dorsal or ventral to LPBN and some of them medial to the
LPBN. Results from rats with misplaced injections of suramin
or α,β-methylene ATP were also analyzed and reported to
confirm the specificity of the LPBN as the site of injections that
produce the effects on sodium intake.
2.2. Water and 1.8% NaCl intake by satiated or sodium
depleted rats treated with bilateral injections of α,
β-methylene ATP into the LPBN
2.2.1. Sodium depleted rats
ANOVA showed significant differences on sodium depletion-
induced 1.8%NaCl intake comparing rats treatedwith bilateral
injections of different doses of α,β-methylene ATP or saline
into the LPBN [F(3,24)=13.39; p<0.001] (Fig. 2A).
Bilateral injections of the highest dose of α,β-methylene
ATP (4.0 nmol/0.2 μl each site) into the LPBN increased sodium
Fig. 2 – (A) Cumulative 1.8% NaCl intake and (B) cumulative
water intake induced by 24 h of sodium depletion in rats that
received bilateral injections ofα,β-methylene ATP (1.0, 2.0 or
4.0 nmol/0.2 μl) or saline into the LPBN. Results are
expressed as means±S.E.M.; n, number of rats. *Significantly
different from saline.
Fig. 3 – (A) Cumulative 1.8% NaCl intake and (B) cumulative
water intake induced by 24 h sodium depletion in rats that
received bilateral injections of PPADS (4.0 nmol/0.2 μl) or
saline+α,β-methylene ATP (2.0 nmol/0.2 μl) or saline into
the LPBN. Results are expressed asmeans±S.E.M.; n, number
of rats. *Significantly different from all the other treatments
into the LPBN.
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test with p values ranging from p<0.01 at 15 min to p<0.001
from 45 to 120 min (Newman–Keuls post hoc test) (Fig. 2A).
The injections of the intermediate dose of α,β-methylene ATP
(2.0 nmol/0.2 μl each site) into the LPBN increased sodium
depletion-induced 1.8% NaCl intake from 45 to 120 min of test
with p values ranging from p<0.005 (at 45 min) to p<0.001
(from 60 to 120 min, Newman–Keuls post hoc test) (Fig. 2A).
Bilateral injections of the lowest dose of α,β-methylene ATP
(1.0 nmol/0.2 μl each site) into the LPBNdid not change sodium
depletion-induced 1.8% NaCl intake (Fig. 2A).
Injections of α,β-methylene ATP (1.0, 2.0 and 4.0 nmol/0.2 μl)
producednoeffect onwater intake (3.5±1.1, 1.3±0.8, 4.4±1.2 ml/
120 min, respectively, vs. vehicle: 3.3±1.4 ml/120 min) [F(3,24)=
1.56; p>0.05] (Fig. 2B).
2.2.2. Sodium replete rats
Bilateral injections of α,β-methylene ATP (2.0 nmol/0.2 μl each
site) into the LPBN in sodium replete rats produced no effecton 1.8% NaCl (1.3±0.9 vs. saline: 0.8±0.4 ml/120 min, n=6) or
water intake (0.2±0.1 vs. saline: 0.6±0.3 ml/120 min).
2.3. Water and 1.8% NaCl intake by sodium depleted rats
treated with bilateral injections α,β-methylene ATP combined
with PPADS, suramin or saline into the LPBN
2.3.1. Water and 1.8% NaCl intake by rats treated with
α,β-methylene ATP after pretreatment with PPADS or saline into
the LPBN
ANOVA showed significant differences on sodium depletion-
induced 1.8%NaCl intake comparing rats treatedwith bilateral
injections of α,β-methylene ATP (2.0 nmol/0.2 μl each site) or
saline after pretreatment with PPADS (4 nmol/0.2 μl) or saline
into the LPBN [F(3,27)=10.97; p<0.001] (Fig. 3A).
Bilateral injections of α,β-methylene ATP (2.0 nmol/0.2 μl
each site) after pretreatment with saline into the LPBN
increased sodium depletion-induced 1.8% NaCl intake from
30 to 120 min of the test with p values ranging from p<0.05 at
Fig. 4 – (A) Cumulative 1.8% NaCl intake and (B) cumulative
water intake induced by 24 h sodium depletion in rats that
received bilateral injections of suramin (2.0 nmol/0.2 μl) or
saline+α,β-methylene ATP (2.0 nmol/0.2 μl) or saline into
the LPBN. Results are expressed asmeans±S.E.M.; n, number
of rats. *Significantly different from saline+saline or from
suramin+α,β-methylene ATP.
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test) (Fig. 3A).
Bilateral injections of PPADS (4 nmol/0.2 μl)+saline into the
LPBN did not change 1.8% NaCl intake (p≥0.1 at any of the
times studied, Newman–Keuls post hoc test) (Fig. 3A). PPADS
(4 nmol/0.2 μl)+α,β-methylene ATP (2.0 nmol/0.2 μl) bilateral-
ly injected into the LPBN abolished the effects of α,β-
methylene ATP in 1.8% NaCl intake by rats treated with
FURO (Fig. 3A). For all the times tested, sodium depletion-
induced 1.8% NaCl intake after PPADS+α,β-methylene ATP
into the LPBN was not different from control test with saline
injections into the LPBN (p>0.1, Newman–Keuls post hoc test)
(Fig. 3A). However, sodium depletion-induced 1.8% NaCl
intake after PPADS+α,β-methylene ATP into the LPBN was
significantly different from the intake after saline combined
with α,β-methylene ATP injections into the LPBN for all the
times tested, with p values ranging from p<0.05 at 15 min to
p<0.001 from 30 to 120 min (Newman–Keuls post hoc test)
(Fig. 3A).
Injections of α,β-methylene ATP or PPADS alone or
combined into the LPBN produced no effect on water intake
by sodium depleted rats [F(3,27)=0.13; p>0.05] (Fig. 3B).
2.3.2. Water and 1.8% NaCl intake by rats treated with
α,β-methylene ATP after pretreatment with suramin or saline
into the LPBN
ANOVA showed significant differences on sodium depletion-
induced 1.8%NaCl intake comparing rats treatedwith bilateral
injections of α,β-methylene ATP (2.0 nmol/0.2 μl each site) or
saline after pretreatment with suramin (2 nmol/0.2 μl) or
saline into the LPBN [F(3,24)=35.47; p<0.001] (Fig. 4A).
Bilateral injections of α,β-methylene ATP (2.0 nmol/0.2 μl
each site) after pretreatment with saline into the LPBN
increased sodium depletion-induced 1.8% NaCl intake from
30 to 120 min of the test with p values ranging from p<0.05 at
30 min to p<0.001 from 45 to 120 min (Newman–Keuls post
hoc test) (Fig. 4A). In contrast, bilateral injections of suramin
(2 nmol/0.2 μl)+saline into the LPBN decreased sodium deple-
tion-induced 1.8% NaCl intake from 15 to 120 min of the test
(p<0.001 for all the times, Newman–Keuls post hoc test)
(Fig. 4A).
Unlike bilateral injections of suramin or α,β-methylene
ATP+saline into the LPBN, the combination of suramin and
α,β-methylene ATP into the LPBN produced no change in 1.8%
NaCl intake by rats treated with FURO (Fig. 4A). For all the
times tested, sodiumdepletion-induced 1.8%NaCl intake after
suramin+α,β-methylene ATP into the LPBN was not different
from control test with saline injections into the LPBN (p>0.5
for all times, Newman–Keuls post hoc test) (Fig. 4A). However,
sodium depletion-induced 1.8% NaCl intake after suramin
+α,β-methylene ATP into the LPBN was significantly different
from 1.8% NaCl intake after saline+α,β-methylene ATP
injections into the LPBN from 30 to 120 min of the test, with
p values ranging from p<0.05 at 30 min to p<0.001 from 45 to
120 min (Newman–Keuls post hoc test) (Fig. 4A). Sodium
depletion-induced 1.8% NaCl intake after combining suramin
and α,β-methylene ATP into the LPBN was also significantly
different from 1.8% NaCl intake after saline+suramin injec-
tions into the LPBN from 15 to 120 min of test (p<0.001 for all
the times, Newman–Keuls post hoc test) (Fig. 4A).Injections of α,β-methylene ATP or suramin alone or
combined into the LPBN produced no significant effect on
water intake by sodium depleted rats [F(3,24)=1.88; p>0.05]
(Fig. 4B).
2.4. Water or 2% sucrose intake by rats treated with
bilateral injections of suramin into the LPBN
2.4.1. Water and 2% sucrose intake by satiated rats treated
with suramin into the LPBN
Bilateral injections of suramin (2.0 nmol/0.2 μl each site) into
the LPBN increased 2% sucrose intake (7.1±1.3 vs. saline: 5.3±
0.8 ml/90 min) as suggested by the significant interaction
between treatments and times [F(5,35)=4.42; p<0.05] (Fig. 5A);
however, injections of suramin into the LPBN produced no
effect on water intake (0.3±0.1 vs. saline: 0.1±0.1 ml/120 min)
[F(1,7)=1.42; p>0.05] (Fig. 5B).
Fig. 5 – (A) Cumulative 2.0% sucrose intake and (B) cumulative
water intake in rats that received bilateral injections of
suramin (2.0 nmol/0.2 μl) or saline into the LPBN. Results are
expressed as mean±S.E.M.; n, number of rats. *Significantly
different from saline.
Table 1 – Cumulative 2% sucrose intake induced by 24 h of
food deprivation in rats treated with bilateral injections of
suramin or saline into LPBN.
LPBN
treatment
2% sucrose intake (ml)
30 min 60 min 90 min 120 min
Saline 6.5±0.8 11.7±1.2 14.6±1.8 17.0±2.7
Suramin 8.7±1.3 14.3±1.7 17.1±2.2 20.2±3.8
Values are means±S.E.M. n=06 rats. The dose of suramin was
2.0 nmol/0.2 μl.
Table 2 – Cumulative water intake induced by 24 h of
water deprivation in rats that received bilateral injections
of suramin or saline into LPBN.
LPBN
treatment
Water intake (ml)
30 min 60 min 90 min 120 min
Saline 9.1±2.1 13.1±1.9 14.7±2.2 15.0±2.1
Suramin 10.8±1.3 14.9±1.9 16.2±1.8 16.7±1.8
Values are means±S.E.M. n=07 rats. The dose of suramin was
2.0 nmol/0.2 μl.
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treated with suramin into the LPBN
Bilateral injections of suramin (2.0 nmol/0.2 μl each site) into
the LPBN produced no change in 2% sucrose intake by 24 h
food deprived rats [F(1,5)=5.7; p>0.05] (Table 1).
2.4.3. Water intake by 24 h water deprived rats treated with
suramin into the LPBN
Bilateral injections of suramin (2.0 nmol/0.2 μl each site) into
the LPBN produced no change on 24 h of water deprivation-
induced water intake [F(1,6)=0.37; p>0.05] (Table 2).
2.5. Water and 1.8% NaCl intake by sodium depleted rats
that received injections of α,β-methylene ATP or suramin in
sites outside of the LPBN
To confirm that the LPBN is the site in which injections of α,β-
methylene ATP (2.0 nmol/0.2 μl) or suramin (2.0 nmol/0.2 μl)
produced effects on sodium depletion-induced 1.8% NaCl
intake, results from rats with misplaced injections (dorsal,
ventral or medial to the LPBN) were also analyzed.
Bilateral injections of α,β-methylene ATP (2.0 nmol/0.2 μl)
or suramin (2.0 nmol/0.2 μl) in sites outside of the LPBNproduced no change in 1.8% NaCl [F(1,7)=2.44; p>0.05] and [F
(1,7)=1.01; p>0.05], respectively or in water intake [F(1,7)=1.30;
p>0.05] and [F(1,7)=3.26; p>0.05], respectively (Table 3).3. Discussion
The present data show that bilateral injections of the P2X
purinergic receptor agonist (α,β-methylene ATP) into the LPBN
increase sodium depletion-induced NaCl intake. Injections of
the selective P2X antagonist, PPADS, alone had no effect on
sodium intake, however, it abolished the increase of sodium
intake produced by α,β-methylene ATP, suggesting that α,β-
methylene ATP may act on P2X purinergic receptors in the
LPBN to facilitate sodium depletion-induced sodium intake.
Unlike PPADS, the non-selective P2 antagonist, suramin,
injected alone into the LPBN reduced sodium depletion-
induced sodium intake, which suggests that purinergic P2
receptors in the LPBN are part of the pathways activated by
sodium depletion to induce sodium intake. Unexpectedly, the
combination of suramin and α,β-methylene ATP in the LPBN
produced no change in sodium depletion-induced sodium
intake, which suggests that each one acts on different
receptors, producing opposite effects that, together, result in
no net change in sodium intake. Injections of suramin or α,β-
methylene ATP in sites outside the LPBN produced no effect on
sodium depletion-induced NaCl intake, which confirms the
specificity of LPBN as the site of injections that produced the
effects on NaCl intake. The ingestion of hypertonic sodium by
sodium depleted rats usually drives rats to ingest a small and
variable amount of water and this ingestion of water was not
affected by treatments with agonist or antagonists of pur-
inergic P2 receptors in the LPBN. Suramin into the LPBN
slightly increased 2% sucrose intake and did not affect food
deprivation-induced 2% sucrose intake or water deprivation-
Table 3 –Water and 1.8% NaCl intake by sodium depleted
rats that received bilateral injections of suramin, α,β-
methylene ATP or saline in sites outside the LPBN.
LPBN treatment 1.8% NaCl intake
(ml/120 min)
Water intake
(ml/120 min)
Saline 16.9±1.0 4.1±1.4
Suramin 16.0±1.4 1.0±0.6
Saline 18.9±1.5 2.6±1.2
α,β-methylene ATP 16.8±1.1 0.9±0.4
Values are means±S.E.M. n=08 rats/group. The dose of suramin
was 2.0 nmol/0.2 μl and the dose of α,β-methylene ATP was
2.0 nmol/0.2 μl.
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intake by suramin into the LPBN is not due to non-specific
inhibition of ingestive behaviors.
Evidence for the involvement of LPBN in the control of
water intake arose by studies showing that electrolytic or
chemical (ibotenic acid) lesions of the LPBN increased ANG II-
induced water intake (Ohman and Johnson, 1986, 1989;
Johnson and Edwards, 1990; Edwards and Johnson, 1991).
Similar to these results from LPBN-lesioned rats, it was also
shown that bilateral injections of lidocaine or methysergide
into the LPBN also increased ANG II-induced water intake
(Menani and Johnson, 1995). Early studies also showed that
bilateral injections of methysergide into the LPBN increased
NaCl intake induced by different stimuli and that proglumide
(a CCK receptor antagonist) into the LPBN increased hyper-
tonic NaCl intake induced by i.c.v. ANG II or FURO+captopril s.
c. (Menani et al., 1996, 1998a, 2000; Menani and Johnson, 1998;
De Gobbi et al., 2000). In addition to serotonin and CCK,
glutamate and CRF, acting in the LPBN, inhibit sodium and
water intake, whereas GABAergic, opioid and adrenergic
agonists acting in the LPBN facilitate sodium intake (Menani
et al., 1996, 1998a,b, 2000; De Gobbi et al., 2000, 2009; Fratucci
De Gobbi et al., 2001; Andrade et al., 2004, 2006; Callera et al.,
2005; De Castro e Silva et al., 2005; De Oliveira et al., 2008;
Gasparini et al., 2009; Andrade-Franzé et al., 2010). Therefore,
all these studies suggest that inhibition or facilitation of
sodium and occasionally water intake by different neuro-
transmitters in the LPBN is probably related to activation or
deactivation of LPBN inhibitory mechanisms, respectively.
The present results suggest that activation of P2 purinergic
receptors in the LPBN facilitate sodium depletion-induced
hypertonic NaCl intake. Therefore, similar to GABAergic,
opioid or adrenergic activation in the LPBN, P2 purinergic
receptor activation in the LPBN facilitates sodium intake by
likely deactivating LPBN inhibitory mechanisms.
Functional studies have suggested the involvement of
purinergic mechanisms in the control of cardio-respiratory
and thermal regulation (Ergene et al., 1994; Barraco et al., 1996;
Phillis et al., 1997; Scislo et al., 1997, 1998; Gourine et al., 2002,
2003, 2004, 2005; de Paula et al., 2004; Antunes et al., 2005a,b).
The present study is the first evidence showing the involve-
ment of central purinergicmechanisms in the control of fluid–
electrolyte balance and, more specifically, of NaCl intake.
Similar to the blockade of serotoninergic and cholecystoki-
nergic mechanisms in the LPBN, activation of purinergic P2Xreceptors in the LPBN increased 1.8% NaCl intake by sodium
depleted rats; however, the same dose of α,β-methylene ATP
injected into the LPBN produced no change in 1.8%NaCl intake
by sodium replete rats. Therefore, the present results clearly
show that purinergic mechanisms in the LPBN facilitate
sodium ingestion induced by the activation of an excitatory
mechanism like those activated by sodium depletion. Results
showed no evidence that activation of purinergic P2X recep-
tors in the LPBNmay affect sodium or water intake by satiated
rats, however, only one dose of α,β-methylene ATP was tested
in satiated rats. Therefore, more studies testing the effects of
higher doses of α,β-methylene ATP injected into the LPBN in
satiated rats are necessary to confirm this suggestion.
Injections of PPADS into the LPBN at the same dose that
blocked the effects of α,β-methylene ATP produced no change
in NaCl intake induced by sodium depletion. Therefore,
although P2X receptor activation in the LPBN facilitates
sodium depletion-induced NaCl intake, it seems that the
activation of these receptors is not necessary for sodium
ingestion by sodium depleted rats. In contrast to PPADS,
suramin, a non-selective P2 purinergic antagonist into the
LPBN almost abolished sodium depletion-induced NaCl in-
take, suggesting that activation of purinergic receptors in the
LPBN is essential for NaCl intake by sodium depleted rats.
More specifically, sodium appetite arises only if purinergic
mechanisms are activated. In addition, a specific subpopula-
tion of P2X receptors may block inhibitory mechanisms,
thereby further increasing salt intake.
Suramin or α,β-methylene ATP injection into the LPBN
produced opposite effects onNaCl intake but, when combined,
they produced no effect. Considering that suramin might
block purinergic P2X and P2Y receptors (Ralevic and Burn-
stock, 1998), no effect of α,β-methylene ATP was expected
after suramin. However, injections of α,β-methylene ATP
reduced the effects of suramin in the LPBN, which suggests
that α,β-methylene ATP was still acting and produced effects
opposite to that of suramin. Thus, no change in sodium intake
was observed. Although suramin is a non-specific antagonist
for P2X and P2Y receptors, it has been suggested that suramin
may not block P2X4 and P2X6 receptor subtypes (Ralevic and
Burnstock, 1998), which might be activated by α,β-methylene
ATP to facilitate sodium intake and oppose the effects of
suramin. Further studies testing the effects of agonists and
antagonists for different purinergic receptors in the LPBN are
necessary to investigate this possibility.
Although the present results clearly show that purinergic
mechanisms in the LPBN are involved in the control of sodium
intake, it is important to consider that they probably do not act
alone and may interact with other neurotransmitters in the
LPBN to control this behavior. Studies have suggested that
different neurotransmitters like serotonin, CCK, glutamate,
CRF, noradrenaline, GABA and opioids modulate sodium and
water intake in the LPBN (Colombari et al., 1996; Menani et al.,
1996, 1998a; Menani and Johnson, 1998; De Gobbi et al., 2000,
2009; Andrade et al., 2004, 2006; Callera et al., 2005; de Oliveira
et al., 2007, 2008; Gasparini et al., 2009). ATP may act as a
cotransmitter with noradrenaline and may increase the
release of noradrenaline and GABA (Burnstock, 1986, 2007;
Espallergues et al., 2007). In fact, similar to α,β-methylene ATP,
noradrenaline and GABA in the LPBN facilitate NaCl intake.
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with other neurotransmitters, purinergic receptor activation
in the LPBN might facilitate NaCl intake by increasing the
release of noradrenaline or GABA.
The LPBN is connected with the area postrema (AP) and
nucleus of the solitary tract (NTS) (Norgren, 1981; Shapiro and
Miselis, 1985). The NTS receives signals from arterial baror-
eceptors and cardiopulmonary, gustatory and other visceral
receptors, whereas the AP, an area that lacks a blood-brain
barrier, may also receive humoral signals important in the
control sodium and water intake (Norgren, 1981; Johnson and
Thunhorst, 1997). From the AP/NTS these signals may reach
the LPBN and there they activate inhibitory mechanisms for
sodium and water intake. The present results suggest that
during sodium depletion, activation of purinergic receptors in
the LPBN, alone or in conjunction with other neurotransmit-
ters like noradrenaline or GABA, attenuates the effect of these
inhibitory mechanisms and, therefore, facilitates NaCl intake.
However, more studies are necessary to investigate possible
interactions between purinergic and the other mechanisms of
the LPBN involved in the control of NaCl intake, as well as
inputs to the LPBN that activate these mechanisms.4. Experimental procedures
4.1. Animals
Male Holtzman rats weighing 290–310 g were used. The
animals were housed in individual stainless steel cages with
free access to normal sodium diet (Guabi Rat Chow, Paulínia,
SP, Brazil), water and 1.8% NaCl solution. Room temperature
was maintained at 23±2 °C and humidity at 55±10% with a
12-h light/dark cycle with light onset at 7:30 AM. The
experimental protocols used in the present study were
approved by the Ethical Committee for Animal Care and
Use from the Dentistry School of Araraquara, UNESP Brazil
(Proc. CEEA no. 03/2008) and they followed the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals (NIH publication no. 80-23, 1996, USA). All efforts
were made to minimize animal discomfort and the number
of animals used.4.2. Cerebral cannulas
Rats were anesthetized with ketamine (80 mg/kg of body
weight, Cristália, Itapira, SP, Brazil) combined with xylazine
(7 mg/kg of body weight, Agener União, Embu-Guaçu, SP,
Brazil) and placed in a Kopf stereotaxic instrument. The skull
was leveled between bregma and lambda. Bilateral stainless
steel 23-gauge cannulas were implanted to target the LPBN
using the following coordinates: 9.4 mm caudal to bregma,
2.1 mm lateral to the midline, and 4.2 mm below the dura
mater (Paxinos and Watson, 1997). The tips of the cannulas
were positioned at a point 2 mm above each LPBN. The
cannulas were fixed to the cranium using dental acrylic
resin and jeweler screws. A 30-gauge metal obturator filled
the cannulas between tests. The rats were allowed to recover
6 days before drug injections into the LPBN.4.3. Injections into the LPBN
Bilateral injections into the LPBN were made using 5-μl
Hamilton syringes connected by polyethylene tubing (PE-10)
to 30-gauge injection cannulas. At time of testing, obturators
were removed and the injection needle (2 mm longer than the
guide cannulas) was introduced in the brain. All the injections
into the LPBN were 0.2 μl for each site and performed over a
period of 1 min, with 1 additional min allowed to elapse before
the injection needle was removed from the guide cannula to
avoid reflux. The movement of an air bubble inside the PE 10
polyethylene tubing connected to the syringe confirmed drug
flow. The obturators were replaced after injection, and the rats
were placed back into the cage.
4.4. Drugs
Furosemide (FURO, 20 mg/kg of body weight, Sigma Chem., St.
Louis, MO, USA) dissolved in alkaline saline (pH adjusted to 9.0
with NaOH) was administered s.c. Pyridoxalphosphate-6-
azophenyl-2',4'-disulfonic acid (PPADS, 4.0 nmol/0.2 μl, a P2X
purinergic receptor antagonist), suramin (2.0 nmol/0.2 μl, a
non-selective P2 purinergic receptor antagonist) and α,β-
methyleneadenosine 5′-triphosphate (α,β-methylene ATP,
1.0, 2.0 and 4.0 nmol/0.2 μl, a P2X purinergic receptor agonist)
from Sigma Chemical, St. Louis, MO were administered into
the LPBN. Suramin, PPADS and α,β-methylene ATP were
dissolved in isotonic saline. Doses of drugs injected into the
LPBN were based on a previous study (de Paula et al., 2004).
4.5. Histology
At the end of the tests, the animals received bilateral
injections of 2% Evans Blue dye solution (0.2 μl) into the
LPBN. They were then deeply anesthetized with sodium
thiopental (80 mg/kg of body weight) and perfused transcar-
dially with saline followed by 10% formalin. The brains were
removed, fixed in 10% formalin, frozen, cut in 50-μm sections,
stained with Giemsa, and analyzed by light microscopy to
confirm the injection sites in the LPBN.
4.6. Statistical analysis
The results are reported as means±S.E.M. Two-way analysis
of variance (ANOVA) with repeated measures for both factors
(treatments and times), followed by Newman–Keuls post hoc
test was used to analyze the results, except 1.8% NaCl and
water intake by rats with injections outside the LPBN which
were analyzed by one-way ANOVA. Differences were consid-
ered significant at p<0.05. Statistical analysis was performed
using Sigma Plot 11 from Systat Software, Inc.
4.7. Experimental protocols
4.7.1. Water and 1.8% NaCl intake by satiated or sodium
depleted rats treated with bilateral injections of α,β-methylene
ATP into the LPBN
4.7.1.1. Sodium depleted rats. Food, water and 1.8% NaCl
were removed and the cageswere rinsedwithwater. Ratswere
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followed by free access to water and sodium-deficient food
(powdered cornmeal; 0.001% sodiumand 0.33% potassium) for
24 h (sodium depletion). After this period, water and sodium-
deficient food were removed from the cages and rats received
injections of drugs into the LPBN. Ten minutes later, rats were
given water and 1.8% NaCl in 0.1-ml graduated glass burettes
fitted with stainless steel spouts. Cumulative water and 1.8%
NaCl intakes were recorded at 15, 30, 60, 90 and 120 min.
Treatment with FURO and sodium-deficient diet produced
losses of 1.5 to 2.0 mEq of sodium per rat in 24 h, which
induces a consistent intake of hypertonic sodium solutions
(De Luca et al., 1992; Jalowiec, 1974; Rowland and Fregly, 1992;
Sakai et al., 1989).
To study the effects of different doses of α,β-methylene
ATP (1.0, 2.0 and 4.0 nmol/0.2 μl) into the LPBN, one group of
rats was submitted to four tests. In each test, the group of rats
was divided in two, and each half received a different drug
treatment into the LPBN (saline or one of the three doses of
α,β-methylene ATP). The sequence of drug treatments was
randomized; all animals received all four treatments. The
interval between tests was 72 h.
4.7.1.2. Sodium replete rats. To test if injections of α,β-
methylene ATP into the LPBN of sodium replete rats would
affect water and 1.8% NaCl intake, another group of rats not
treated with FURO received bilateral injections of α,β-methy-
lene ATP (2.0 nmol/0.2 μl) or saline into the LPBN and 10 min
later rats were given water and 1.8% NaCl. Cumulative water
and 1.8% NaCl intake was measured at 15, 30, 60, 90, and
120 min. This group of rats was submitted to two tests. In the
first test, half of the group received bilateral injections of α,β-
methylene ATP into the LPBN and the other half received
injections of saline into the LPBN. In the next test, rats
received the same treatments into the LPBN in a counter-
balanced design. The interval between the two tests was 48 h.
4.7.2. Water and 1.8% NaCl intake by sodium depleted rats
treated with bilateral injections α,β-methylene ATP or saline
after pretreatment with PPADS, suramin or saline into the LPBN
4.7.2.1. Water and 1.8% NaCl intake by rats treated with
α,β-methylene ATP or saline after pretreatment with PPADS
or saline into the LPBN. In a group of rats submitted to
sodium depletion as described above (Section 4.7.1a), PPADS
(4 nmol/0.2 μl) or saline was bilaterally injected into the LPBN
15 min prior to injections of α,β-methylene ATP (2 nmol/0.2 μl)
or saline into the LPBN. Therefore, this group of rats received
four combinations of treatments into the LPBN: saline+saline;
saline+α,β-methylene ATP, PPADS+α,β-methylene ATP and
PPADS+saline. In each test, the group of rats was divided in
two and each half of the group received one of the four
combinations indicated above. The sequencewas randomized;
all animals received all four treatments. The interval between
tests was 72 h.
4.7.2.2. Water and 1.8% NaCl intake by rats treated with α,β-
methylene ATP or saline after pretreatment with suramin or
saline into the LPBN. In another group of rats submitted to
sodium depletion as described above (Section 4.7.1a), suramin(2 nmol/0.2 μl) or saline was bilaterally injected into the LPBN
15 min prior to injections of α,β-methylene ATP (2 nmol/0.2 μl)
or saline. This group of rats was also submitted to four tests,
following the same protocol described above, except that
suramin instead of PPADS was injected into the LPBN. The
interval between tests was 72 h.
4.7.3. Water or 2% sucrose intake by rats treated with
bilateral injections of suramin into the LPBN
To confirm that the inhibition of sodium depletion-induced
1.8% NaCl intake by suramin into the LPBN is not due to non-
specific inhibition of all ingestive behaviors, ad libitum 2%
sucrose intake, food deprivation induced 2% sucrose intake or
water deprivation induced water intake were tested after
injections of suramin into the LPBN.
4.7.3.1. Water and sucrose intake by satiated rats treated with
suramin into the LPBN. A group of ratswith ad libitumaccess
to food and water had also access to 2% sucrose for 2 h every
day for 1week. After this period of training, suramin (2.0 nmol/
0.2 μl) or saline was injected bilaterally into the LPBN, 10 min
before rats were given 2% sucrose solution. Cumulative water
and 2% sucrose solution intake was measured at each 15 min
for 2 h. This group of rats was submitted to two tests. In the
first test, half of the group received bilateral injections of
suramin into the LPBN and the other half received injections
of saline into the LPBN. In the next test, rats received the same
treatments into the LPBN in a counterbalanced design. The
interval between the two tests was 48 h.
4.7.3.2. Food deprivation-induced 2% sucrose intake by rats
treated with suramin into the LPBN. Another group of rats
had food removed from the cage, whereas water was
available. Twenty-four hours after starting food deprivation,
the animals received suramin (2.0 nmol/0.2 μl) or saline into
the LPBN. Ten minutes after the injections, rats had access to
2% sucrose. Cumulative 2% sucrose intake was measured at
each 30 min for 2 h in the absence of food. This group of rats
was also submitted to two tests, following the same counter-
balanced design described previously to test sucrose intake by
satiated rats. The interval between the two tests was 72 h.
4.7.3.3. Water intake induced by 24 h of water deprivation in
rats treated with suramin into the LPBN. Another group of
rats had only food pellets available for 24 h. After this period,
food was removed and suramin (2.0 nmol/0.2 μl) or saline was
injected into the LPBN 10 min before access to water.
Cumulative water intake was measured at each 30 min for
2 h in the absence of food. This group of rats was also
submitted to two tests, following the same counterbalanced
design described previously for sucrose intake test. The
interval between the two tests was 72 h.Acknowledgments
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